Press release year list 2021 2020 2019 2018 2017 2016
11/09/2021
Evaxion Biotech Announces Closing of $27.6 Million Follow-on Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
11/09/2021
Evaxion Biotech Announces Q3 2021 Financial Results and Provides Business Update
11/05/2021
Evaxion Biotech Announces Pricing of $24.0 Million Follow-on Public Offering
10/26/2021
Evaxion Biotech Announces Filing of Registration Statement in the U.S for Proposed Follow-on Public Offering to Raise Additional Capital
10/25/2021
Evaxion Biotech Announces Clinical Collaboration to Evaluate Lead Product Candidate with KEYTRUDA® (pembrolizumab) in Patients with Melanoma
10/14/2021
Evaxion Biotech Wins Frost & Sullivan 2021 Enabling Technology Leadership Award
DownloadPDF format download (opens in new window)
10/12/2021
Evaxion Biotech to Present Work on AI-Immunology Core Technology at Immuno UK 2021
09/21/2021
Evaxion Biotech Appoints Dr. Birgitte Rønø as Chief Scientific Officer
08/12/2021
Evaxion Biotech Announces Q2 2021 Financial Results and Provides Business Update
07/08/2021
Evaxion Biotech Reports Data from Phase 1/2a Trials of EVX-01 and EVX-02
07/07/2021
Evaxion Biotech to Host Conference Call on EVX-01 and EVX-02 Phase 1/2a Data on July 8
06/25/2021
Evaxion Develops Method to Enhance AI Drug Development with Deep Probabilistic Programming
06/03/2021
Evaxion Biotech Reports Preclinical Proof of Concept Data for Evaxion’s AI-powered Vaccine Platform RAVEN for the Design of a Next Generation SARS-CoV-2 Vaccine
05/26/2021
Evaxion Biotech Appoints Lars Holtug to the Board of Directors
05/13/2021
Evaxion Biotech Announces Q1 2021 Financial Results and Provides Business Update
DownloadPDF format download (opens in new window)
05/06/2021
Evaxion Biotech to Host Q1 2021 Corporate Update Conference Call & Webcast on May 13
04/20/2021
Evaxion Biotech Presents Paper on Potential of Deep Data on Immune Complex Stability to Optimize Cancer Immunotherapy
04/06/2021
Evaxion Biotech Announces Q4 and Full-Year 2020 Financial Results and Provides Business Update
03/30/2021
Evaxion Biotech to Host Full-Year 2020 Corporate Update Conference Call & Webcast on April 6
03/16/2021
Evaxion Biotech Announces Publication of Study on S. aureus Bacterium in Scientific Reports
02/16/2021
Evaxion Biotech Opens New Office and Laboratories to Support Future Growth
02/10/2021
Evaxion Biotech Closes its U.S. Initial Public Offering of American Depositary Shares
DownloadPDF format download (opens in new window)
02/04/2021
Evaxion Biotech Announces Pricing of Initial Public Offering
DownloadPDF format download (opens in new window)
01/08/2021
Evaxion Biotech Announces Filing of Registration Statement in the U.S. for Proposed Initial Public Offering of Securities
DownloadPDF format download (opens in new window)